Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaNew England Journal of MedicineSeptember 25, 201510.1056/nejmoa1510665Cited by 5,890SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis